Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,108.80
(
-0.36%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
98.42
(
1.76%
)
Bitcoin
77,494.09
(
-0.95%
)
News Focus
News Focus
Post# of 445431
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Couch

Send PM Follow Ignore
Followers 280
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Couch

Re: dr_lowenstein post# 33646

Saturday, 11/03/2012 3:59:27 PM

Saturday, November 03, 2012 3:59:27 PM

Post# of 445431

Elite's initial studies in humans showed results that strongly supported the premise of the ART(TM) including demonstrating little or no release of the antagonist in the intact dosage form. Based upon our investigations to date, similar results are not found in any literature reports.


Do you have any links that show the counter? LOL LOL

This is why Elite will have no problem with BE studies or FDA Phase III.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ELTP News
More ELTP News